{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:04:48Z","timestamp":1792649088395,"version":"4.5.0"},"reference-count":177,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Low-density lipoprotein (LDL) chemically modified by reactive oxygen species (ROS), for example, leaking from red blood cells in the vascular compartment, more readily crosses the vascular endothelium than does nonoxidatively modified LDL to enter tissue fluid. Oxidatively modified LDL (oxLDL) may also be created in the tissue fluid by ROS leaking from cells by design, for example, by inflammatory white cells, or simply leaking from other cells as a consequence of oxygen metabolism. As well as oxLDL, glycatively modified LDL (glycLDL) is formed in the circulation. High-density lipoprotein (HDL) appears capable of decreasing the burden of lipid peroxides formed on LDL exposed to ROS or to glucose and its metabolites. The mechanism for this that has received the most attention is the antioxidant activity of HDL, which is due in large part to the presence of paraoxonase 1 (PON1). PON1 is intimately associated with its apolipoprotein A1 component and with HDL\u2019s lipid domains into which lipid peroxides from LDL or cell membranes can be transferred. It is frequently overlooked that for PON1 to hydrolyze lipid substrates, it is essential that it remain by virtue of its hydrophobic amino acid sequences within a lipid micellar environment, for example, during its isolation from serum or genetically modified cells in tissue culture. Otherwise, it may retain its capacity to hydrolyze water-soluble substrates, such as phenyl acetate, whilst failing to hydrolyze more lipid-soluble molecules. OxLDL and probably glycLDL, once they have crossed the arterial endothelium by receptor-mediated transcytosis, are rapidly taken up by monocytes in a process that also involves scavenger receptors, leading to subendothelial foam cell formation. These are the precursors of atheroma, inducing more monocytes to cross the endothelium into the lesion and the proliferation and migration of myocytes present in the arterial wall into the developing lesion, where they transform into foam cells and fibroblasts. The atheroma progresses to have a central extracellular lake of cholesteryl ester following necrosis and apoptosis of foam cells with an overlying fibrous cap whilst continuing to grow concentrically around the arterial wall by a process involving oxLDL and glycLDL. Within the arterial wall, additional oxLDL is generated by ROS secreted by inflammatory cells and leakage from cells generally when couplet oxygen is reduced. PON1 is important for the mechanism by which HDL opposes atherogenesis, which may provide a better avenue of inquiry in the identification of vulnerable individuals and the provision of new therapies than have emerged from the emphasis placed on its role in RCT.<\/jats:p>","DOI":"10.3390\/antiox14040430","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T05:43:33Z","timestamp":1743572613000},"page":"430","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9561-7887","authenticated-orcid":false,"given":"Paul N.","family":"Durrington","sequence":"first","affiliation":[{"name":"Faculty of Biology, Medicine and Health, Cardiovascular Research Group, University of Manchester, Manchester M13 9NT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-8331","authenticated-orcid":false,"given":"Bilal","family":"Bashir","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Medicine and Health, Cardiovascular Research Group, University of Manchester, Manchester M13 9NT, UK"},{"name":"Department of Diabetes, Endocrinology and Metabolism, Peter Mount Building, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handrean","family":"Soran","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Medicine and Health, Cardiovascular Research Group, University of Manchester, Manchester M13 9NT, UK"},{"name":"Department of Diabetes, Endocrinology and Metabolism, Peter Mount Building, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-023-00937-4","article-title":"Oxidized phospholipids in cardiovascular disease","volume":"21","author":"Tsimikas","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/ATVBAHA.108.179697","article-title":"Oxidized low-density lipoprotein and atherosclerosis","volume":"30","author":"Steinberg","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group (2002). MRC\/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet, 360, 23\u201333.","DOI":"10.1016\/S0140-6736(02)09328-5"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.numecd.2015.01.008","article-title":"Supplementation with vitamin E alone is associated with reduced myocardial infarction: A meta-analysis","volume":"25","author":"Loffredo","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/nutrit\/nuad114","article-title":"Vitamin E supplementation (alone or with other antioxidants) and stroke: A meta-analysis","volume":"82","author":"Maggio","year":"2024","journal-title":"Nutr. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Durrington, P.N., Bashir, B., and Soran, H. (2023). Paraoxonase 1 and atherosclerosis. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1065967"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0021-9150(99)00353-6","article-title":"Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity","volume":"150","author":"Arrol","year":"2000","journal-title":"Atherosclerosis"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Myant, N.B. (1981). The Biology of Cholesterol and Related Steroids, Elsevier.","DOI":"10.1016\/B978-0-433-22880-6.50020-5"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican1184-58","article-title":"How LDL receptors influence cholesterol and atherosclerosis","volume":"251","author":"Brown","year":"1984","journal-title":"Sci. Am."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease","volume":"1","author":"Miller","year":"1975","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and Reverse Cholesterol Transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12944-017-0604-5","article-title":"High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: A systematic review and meta-analysis","volume":"16","author":"Qiu","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCULATIONAHA.118.035358","article-title":"Is Low-Density Lipoprotein Cholesterol the Key to Interpret the Role of Lecithin: Cholesterol Acyltransferase in Atherosclerosis?","volume":"138","author":"Vitali","year":"2018","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: Biological functions and clinical relevance","volume":"44","author":"Nordestgaard","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1567-5688(02)00042-9","article-title":"HDL in risk prediction and its direct and indirect involvement in atherogenesis","volume":"3","author":"Durrington","year":"2002","journal-title":"Atheroscler. Suppl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCRESAHA.119.316424","article-title":"LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models","volume":"127","author":"Metso","year":"2020","journal-title":"Circ. Res."},{"key":"ref_17","first-page":"III28","article-title":"High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations","volume":"87","author":"Assmann","year":"1993","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Durrington, P.N. (2007). Hyperlipidaemia: Diagnosis and Management, Hodder Arnold. [3rd ed.].","DOI":"10.1201\/b13464"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1172\/JCI11538","article-title":"Tangier disease as a test of the reverse cholesterol transport hypothesis","volume":"106","author":"Tall","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.5551\/jat.RV17053","article-title":"Current Diagnosis and Management of Tangier Disease","volume":"28","author":"Koseki","year":"2021","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MED.0b013e328329233b","article-title":"Lecithin: Cholesterol acyltransferase--from biochemistry to role in cardiovascular disease","volume":"16","author":"Rousset","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MOL.0000000000000667","article-title":"Inborn errors of apolipoprotein A-I metabolism: Implications for disease, research and development","volume":"31","author":"Zanoni","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jacl.2017.06.018","article-title":"Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome","volume":"11","author":"Lhomme","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.ATV.17.6.1053","article-title":"Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity","volume":"17","author":"Hirano","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOL.0000000000000332","article-title":"Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation","volume":"27","author":"Yamashita","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2007.12.025","article-title":"Free radical metabolism in human erythrocytes","volume":"390","author":"Cimen","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1016\/S0021-9258(18)34620-9","article-title":"Mechanism of autooxidation for hemoglobins and myoglobins. Promotion of superoxide production by protons and anions","volume":"257","author":"Wallace","year":"1982","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Andr\u00e9s, C.M.C., P\u00e9rez de la Lastra, J.M., Andr\u00e9s Juan, C., Plou, F.J., and P\u00e9rez-Lebe\u00f1a, E. (2023). Superoxide Anion Chemistry-Its Role at the Core of the Innate Immunity. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24031841"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e14081","DOI":"10.1111\/apha.14081","article-title":"Erythrocyte metabolism","volume":"240","author":"Chatzinikolaou","year":"2024","journal-title":"Acta Physiol."},{"key":"ref_30","first-page":"300","article-title":"On the ability of high density lipoproteins to remove phospholipid peroxidation products from erythrocyte membranes","volume":"66","author":"Klimov","year":"2001","journal-title":"Biochemistry"},{"key":"ref_31","first-page":"33","article-title":"High-density-lipoprotein-associated enzymes and the prevention of lower density lipoprotein oxidation","volume":"4","author":"Arrol","year":"1996","journal-title":"Eur. J. Lab. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-2275(20)38354-1","article-title":"A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent","volume":"30","author":"Esterbauer","year":"1989","journal-title":"J. Lipid Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1042\/bj2940829","article-title":"The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation","volume":"294","author":"Mackness","year":"1993","journal-title":"Biochem. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0021-9150(93)90183-U","article-title":"Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase","volume":"104","author":"Mackness","year":"1993","journal-title":"Atherosclerosis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_37","first-page":"772","article-title":"Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidation","volume":"63","author":"Hine","year":"2011","journal-title":"IUBMB Life"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/biof.1890","article-title":"Oxidized phospholipids and lipoprotein-associated phospholipase A2 (Lp-PLA2 ) in atherosclerotic cardiovascular disease: An update","volume":"48","author":"Pantazi","year":"2022","journal-title":"Biofactors"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3540001","article-title":"Hydrolysis of platelet-activating factor by human serum paraoxonase","volume":"354","author":"Rodrigo","year":"2001","journal-title":"Biochem. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0021-9150(91)90005-N","article-title":"An investigation of the role of lecithin:cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins","volume":"89","author":"Neary","year":"1991","journal-title":"Atherosclerosis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/01.ATV.0000104029.74961.f5","article-title":"Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I","volume":"24","author":"Rye","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.81.12.3883","article-title":"Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids","volume":"81","author":"Steinbrecher","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.ATV.4.4.357","article-title":"Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation","volume":"4","author":"Morel","year":"1984","journal-title":"Arteriosclerosis"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Herb, M., and Schramm, M. (2021). Functions of ROS in Macrophages and Antimicrobial Immunity. Antioxidants, 10.","DOI":"10.3390\/antiox10020313"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-2275(20)42092-9","article-title":"Quantification of apo[a] and apoB in human atherosclerotic lesions","volume":"32","author":"Pepin","year":"1991","journal-title":"J. Lipid Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1042\/bst0311066","article-title":"Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein","volume":"31","author":"Packard","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Vekic, J., Zeljkovic, A., Cicero, A.F., Janez, A., Stoian, A.P., Sonmez, A., and Rizzo, M. (2022). Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL. Medicina, 58.","DOI":"10.3390\/medicina58020299"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2008.04.036","article-title":"Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro","volume":"202","author":"Younis","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1479164110383063","article-title":"Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes","volume":"7","author":"Younis","year":"2010","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/CS20120304","article-title":"Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes","volume":"124","author":"Younis","year":"2013","journal-title":"Clin. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2796.2006.01646.x","article-title":"Apolipoproteins AI and B as therapeutic targets","volume":"259","author":"Durrington","year":"2006","journal-title":"J. Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MOL.0000000000000614","article-title":"Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia","volume":"30","author":"Soran","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0021-9150(92)90260-N","article-title":"Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects","volume":"93","author":"Tames","year":"1992","journal-title":"Atherosclerosis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MOL.0b013e328306a057","article-title":"Glycation as an atherogenic modification of LDL","volume":"19","author":"Younis","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1479164112454309","article-title":"High-density lipoprotein impedes glycation of low-density lipoprotein","volume":"10","author":"Younis","year":"2013","journal-title":"Diab Vasc. Dis. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1749-6632.2001.tb05634.x","article-title":"Protein glycation: Creation of catalytic sites for free radical generation","volume":"928","author":"Yim","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","article-title":"Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells","volume":"52","author":"Empsen","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.18097\/pbmc20125803339","article-title":"The influence of glucose on the free radical peroxidation of low density lipoproteins in vitro and in vivo","volume":"58","author":"Lankin","year":"2012","journal-title":"Biomed. Khim."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3085756","DOI":"10.1155\/2019\/3085756","article-title":"Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases","volume":"2019","author":"Moldogazieva","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0009-8981(97)00067-3","article-title":"The effect of delta-gluconolactone, an oxidised analogue of glucose, on the nonenzymatic glycation of human and rat haemoglobin","volume":"263","author":"Lindsay","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.molcel.2019.09.007","article-title":"\u03b3-6-Phosphogluconolactone, a Byproduct of the Oxidative Pentose Phosphate Pathway, Contributes to AMPK Activation through Inhibition of PP2A","volume":"76","author":"Gao","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3440109","article-title":"Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose","volume":"344","author":"Thornalley","year":"1999","journal-title":"Biochem. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2337\/db11-0085","article-title":"Glycation of LDL by methylglyoxal increases arterial atherogenicity: A possible contributor to increased risk of cardiovascular disease in diabetes","volume":"60","author":"Rabbani","year":"2011","journal-title":"Diabetes"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2015.01.140","article-title":"Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease","volume":"458","author":"Rabbani","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Allaman, I., B\u00e9langer, M., and Magistretti, P.J. (2015). Methylglyoxal, the dark side of glycolysis. Front. Neurosci., 9.","DOI":"10.3389\/fnins.2015.00023"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10719-016-9705-z","article-title":"Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics","volume":"33","author":"Rabbani","year":"2016","journal-title":"Glycoconj. J."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lankin, V.Z., Tikhaze, A.K., and Melkumyants, A.M. (2022). Dicarbonyl-Dependent Modification of LDL as a Key Factor of Endothelial Dysfunction and Atherosclerotic Vascular Wall Damage. Antioxidants, 11.","DOI":"10.3390\/antiox11081565"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12551-024-01188-4","article-title":"An overview on glycation: Molecular mechanisms, impact on proteins, pathogenesis, and inhibition","volume":"16","author":"Uceda","year":"2024","journal-title":"Biophys. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0005-2760(81)90129-6","article-title":"Binding of plasma low density lipoproteins to erythrocytes","volume":"664","author":"Hui","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-94-2-211","article-title":"Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency","volume":"94","author":"Durrington","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2040-2384-2-14","article-title":"Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability","volume":"2","author":"Sarin","year":"2010","journal-title":"J. Angiogenes Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1194\/jlr.M055053","article-title":"LDL and HDL transfer rates across peripheral microvascular endothelium agree with those predicted for passive ultrafiltration in humans","volume":"56","author":"Michel","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0014-5793(97)01243-X","article-title":"Presence of paraoxonase in human interstitial fluid","volume":"416","author":"Mackness","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"854","DOI":"10.5551\/jat.RV22017","article-title":"In the Beginning, Lipoproteins Cross the Endothelial Barrier","volume":"31","author":"Goldberg","year":"2024","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1515\/CCLM.2003.120","article-title":"Identification of lipoproteins of intestinal origin in human atherosclerotic plaque","volume":"41","author":"Pal","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2007.12.012","article-title":"Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases","volume":"390","author":"Nakano","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0741-5214(89)90222-X","article-title":"Particle size distribution of lipoproteins from human atherosclerotic plaque: A preliminary report","volume":"9","author":"Rapp","year":"1989","journal-title":"J. Vasc. Surg."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0033-0620(76)90002-5","article-title":"Abnormalities of the arterial wall and its metabolism in atherogenesis","volume":"18","author":"Wissler","year":"1976","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/clc.4960141302","article-title":"The pathogenesis of atherosclerosis: An overview","volume":"14","author":"Schwartz","year":"1991","journal-title":"Clin. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Weinberg, P.D. (2022). Haemodynamic Wall Shear Stress, Endothelial Permeability and Atherosclerosis-A Triad of Controversy. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.836680"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cvr\/cvv147","article-title":"Monocyte trafficking across the vessel wall","volume":"107","author":"Gerhardt","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Medrano-Bosch, M., Sim\u00f3n-Codina, B., Jim\u00e9nez, W., Edelman, E.R., and Melgar-Lesmes, P. (2023). Monocyte-endothelial cell interactions in vascular and tissue remodeling. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1196033"},{"key":"ref_83","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Grechko, A.V., Orekhova, V.A., Khotina, V., Ivanova, E.A., and Orekhov, A.N. (2020). NADPH Oxidases and Their Role in Atherosclerosis. Biomedicines, 8.","DOI":"10.3390\/biomedicines8070206"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2796.2006.01621.x","article-title":"Endothelial mechanotransduction, nitric oxide and vascular inflammation","volume":"259","author":"Harrison","year":"2006","journal-title":"J. Intern. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/CIRCRESAHA.122.320263","article-title":"Animal Models of Atherosclerosis-Supportive Notes and Tricks of the Trade","volume":"130","author":"Ketelhuth","year":"2022","journal-title":"Circ. Res."},{"key":"ref_87","first-page":"12","article-title":"Current concepts of the pathogenesis of atherosclerosis in light of the development of N.N. Anichkov\u2019s theory (on the centenary of his birth)","volume":"47","author":"Klimov","year":"1985","journal-title":"Arkhiv Patol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.1073\/pnas.0406073101","article-title":"Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature","volume":"101","author":"Dai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"H126","DOI":"10.1152\/ajpheart.01188.2006","article-title":"In vitro study of LDL transport under pressurized (convective) conditions","volume":"293","author":"Cancel","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"H983","DOI":"10.1152\/ajpheart.00324.2009","article-title":"The transport of LDL across the deformable arterial wall: The effect of endothelial cell turnover and intimal deformation under hypertension","volume":"297","author":"Dabagh","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_91","first-page":"16","article-title":"Lipoproteins and atherosclerosis in children: An early marriage?","volume":"11","author":"Strong","year":"2001","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/bmj.303.6797.276","article-title":"Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations","volume":"303","author":"Chen","year":"1991","journal-title":"BMJ"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Lorey, M.B., \u00d6\u00f6rni, K., and Kovanen, P.T. (2022). Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.841545"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Zhang, X., Sessa, W.C., and Fern\u00e1ndez-Hernando, C. (2018). Endothelial Transcytosis of Lipoproteins in Atherosclerosis. Front. Cardiovasc. Med., 5.","DOI":"10.3389\/fcvm.2018.00130"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1140-4","article-title":"SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis","volume":"569","author":"Huang","year":"2019","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOL.0000000000000701","article-title":"Transport of LDLs into the arterial wall: Impact in atherosclerosis","volume":"31","author":"Zhang","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/ATVBAHA.120.314557","article-title":"Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2-SR-BI Axis","volume":"41","author":"Ghaffari","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2020.09.020","article-title":"Transendothelial transport of lipoproteins","volume":"315","author":"Jang","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11883-023-01118-x","article-title":"LDL Transcytosis by the Arterial Endothelium-Atherosclerosis by a Thousand Cuts?","volume":"25","author":"Ho","year":"2023","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_100","first-page":"2599","article-title":"Differential roles of Scavenger receptor class B type I: A protective molecule and a facilitator of atherosclerosis (Review)","volume":"22","author":"Ma","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-physiol-021317-121550","article-title":"SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux","volume":"80","author":"Shen","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1111\/bph.15272","article-title":"LDL receptors, caveolae and cholesterol in endothelial dysfunction: oxLDLs accomplices or victims?","volume":"178","author":"Luchetti","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/nyas.13984","article-title":"Targeting LOX-1 in atherosclerosis and vasculopathy: Current knowledge and future perspectives","volume":"1443","author":"Tian","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/eurheartj\/ehaa770","article-title":"Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): A crucial driver of atherosclerotic cardiovascular disease","volume":"42","author":"Akhmedov","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/ATVBAHA.120.315421","article-title":"Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor: Mechanistic Insight and Potential Clinical Use","volume":"41","author":"Barreto","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Cheng, W., Shu, M., Kuang, L., Bai, X., Jia, X., Zhao, Y., Lu, Y., Zhu, L., Wang, L., and Zhu, Y. (2023). Scavenger receptor a mediates glycated LDL transcytosis across endothelial cells to promote atherosclerosis. Int. J. Biol. Macromol., 235.","DOI":"10.1016\/j.ijbiomac.2023.123836"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s10020-023-00715-5","article-title":"AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE\/NF-\u03baB\/Caveolin-1 pathway","volume":"29","author":"Shu","year":"2023","journal-title":"Mol. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2253478","DOI":"10.1155\/2022\/2253478","article-title":"Atherogenesis, Transcytosis, and the Transmural Cholesterol Flux: A Critical Review","volume":"2022","author":"Goldberg","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"100530","DOI":"10.1016\/j.jlr.2024.100530","article-title":"Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1","volume":"65","author":"Fung","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1172\/JCI108772","article-title":"Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts","volume":"60","author":"Miller","year":"1977","journal-title":"J. Clin. Investig."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Gui, Y., Zheng, H., and Cao, R.Y. (2022). Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.845942"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Cuthbert, G.A., Shaik, F., Harrison, M.A., Ponnambalam, S., and Homer-Vanniasinkam, S. (2020). Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease. Cells, 9.","DOI":"10.3390\/cells9112453"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Getz, G.S., and Reardon, C.A. (2018). Apoprotein E and Reverse Cholesterol Transport. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113479"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2004.10.028","article-title":"Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: A possible role for lysophosphatidylcholine","volume":"179","author":"Rosenblat","year":"2005","journal-title":"Atherosclerosis"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2010.09.002","article-title":"HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress","volume":"50","author":"Deakin","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.atherosclerosis.2007.08.027","article-title":"The role of hydrostatic pressure in foam cell formation upon exposure of macrophages to LDL and oxidized LDL","volume":"197","author":"Evans","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOL.0000000000000936","article-title":"Paraoxonase 1: Evolution of the enzyme and of its role in protecting against atherosclerosis","volume":"35","author":"Durrington","year":"2024","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/bj0530117","article-title":"Serum esterases. II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera","volume":"53","author":"Aldridge","year":"1953","journal-title":"Biochem. J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/12.10.744","article-title":"Arylesterases","volume":"12","author":"Augustinsson","year":"1964","journal-title":"J. Histochem. Cytochem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-3083.1975.tb03807.x","article-title":"Enzyme Characterization in Quantitative Immunoelectrophoresis","volume":"4","author":"Brogen","year":"1975","journal-title":"Scand. J. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0305-0491(85)90506-1","article-title":"The separation of sheep and human serum \u201cA\u201d-esterase activity into the lipoprotein fraction by ultracentrifugation","volume":"82","author":"Mackness","year":"1985","journal-title":"Comp. Biochem. Physiol. B"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0009-2797(93)90023-R","article-title":"Human and rabbit paraoxonases: Purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification","volume":"87","author":"Furlong","year":"1993","journal-title":"Chem. Biol. Interact."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00210-003-0833-1","article-title":"Pharmacogenetics of paraoxonases: A brief review","volume":"369","author":"Draganov","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.ATV.17.7.1233","article-title":"Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis","volume":"17","author":"Mackness","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/clinchem\/32.4.671","article-title":"Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction","volume":"32","author":"McElveen","year":"1986","journal-title":"Clin. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.ATV.19.2.330","article-title":"Serum paraoxonase after myocardial infarction","volume":"19","author":"Ayub","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hq0901.094247","article-title":"Paraoxonase status in coronary heart disease: Are activity and concentration more important than genotype?","volume":"21","author":"Mackness","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","article-title":"Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study","volume":"107","author":"Mackness","year":"2003","journal-title":"Circulation"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(91)90215-O","article-title":"Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus","volume":"86","author":"Mackness","year":"1991","journal-title":"Atherosclerosis"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/01.ATV.15.11.1812","article-title":"Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins","volume":"15","author":"Abbott","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2362.2002.00977.x","article-title":"Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls","volume":"32","author":"Mackness","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_133","unstructured":"Liu, Y. (2015). Clinical Study on Apolipoprotein E Distribution, Metabolism and Glycation. [Ph.D. Thesis, University of Manchester]."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1210\/jc.2004-1295","article-title":"Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome","volume":"90","author":"Garin","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1210\/jc.2003-030648","article-title":"Antioxidant paraoxonase 1 activity in the metabolic syndrome","volume":"88","author":"Weinbrenner","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.ATV.0000222924.62641.aa","article-title":"Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome","volume":"26","author":"Mackness","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_137","first-page":"116","article-title":"Paraoxonase activity in metabolic syndrome in children and adolescents","volume":"9","author":"Mogarekar","year":"2018","journal-title":"Casp. J. Intern. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.clinbiochem.2013.08.020","article-title":"Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome","volume":"46","author":"Feliu","year":"2013","journal-title":"Clin. Biochem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.arcmed.2011.05.002","article-title":"Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome","volume":"42","author":"Kappelle","year":"2011","journal-title":"Arch. Med. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/clinem\/dgac244","article-title":"Bariatric Surgery-induced High-density Lipoprotein Functionality Enhancement Is Associated With Reduced Inflammation","volume":"107","author":"Adam","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000505452","article-title":"Association of Paraoxonase 1 Gene Polymorphisms and Polycystic Ovarian Syndrome Susceptibility: A Systematic Review and Meta-Analysis","volume":"85","author":"Jiang","year":"2020","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2376930","DOI":"10.1080\/0886022X.2024.2376930","article-title":"The importance of paraoxonase 1 activity in chronic kidney disease","volume":"46","author":"Samouilidou","year":"2024","journal-title":"Ren. Fail."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(98)00064-7","article-title":"Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification","volume":"423","author":"Mackness","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"116646","DOI":"10.1016\/j.lfs.2019.116646","article-title":"A meta-analysis on relationship between paraoxonase 1 polymorphisms and atherosclerotic cardiovascular diseases","volume":"232","author":"Zeng","year":"2019","journal-title":"Life Sci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10528-021-10043-0","article-title":"The Role of Paraoxonase 1 (PON1) Gene Polymorphisms in Coronary Artery Disease: A Systematic Review and Meta-Analysis","volume":"59","author":"Ashiq","year":"2021","journal-title":"Biochem. Genet."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4264314","DOI":"10.1155\/2022\/4264314","article-title":"Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis","volume":"2022","author":"Zuin","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/bs.acc.2024.04.003","article-title":"Pleiotropic functions and clinical importance of circulating HDL-PON1 complex","volume":"121","author":"Mahrooz","year":"2024","journal-title":"Adv. Clin. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0021-9150(98)00058-6","article-title":"Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states","volume":"139","author":"James","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"23914","DOI":"10.1074\/jbc.M112.427922","article-title":"The evolutionary origins of detoxifying enzymes: The mammalian serum paraoxonases (PONs) relate to bacterial homoserine lactonases","volume":"288","author":"Hugenmatter","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2015.12.021","article-title":"Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies","volume":"245","author":"Kunutsor","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Corsetti, J.P., Sparks, C.E., James, R.W., Bakker, S.J.L., and Dullaart, R.P.F. (2019). Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091357"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOL.0b013e32832ec141","article-title":"Variation in paraoxonase-1 activity and atherosclerosis","volume":"20","author":"Soran","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2019.07.010","article-title":"The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation","volume":"73","author":"Mahrooz","year":"2019","journal-title":"Clin. Biochem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/bbrc.1998.8803","article-title":"Lack of protection against oxidative modification of LDL by avian HDL","volume":"247","author":"Mackness","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1074\/jbc.M910376199","article-title":"Combined serum paraoxonase knockout\/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis","volume":"275","author":"Shih","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.0000023623.87083.4F","article-title":"Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice","volume":"106","author":"Tward","year":"2002","journal-title":"Circulation"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.bjp.0707585","article-title":"Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis","volume":"153","author":"Guns","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.108.192229","article-title":"Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice","volume":"104","author":"She","year":"2009","journal-title":"Circ. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/gt.2010.11","article-title":"Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice","volume":"17","author":"Zhang","year":"2010","journal-title":"Gene Ther."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1074\/jbc.M608135200","article-title":"Phospholipase action of platelet-activating factor acetylhydrolase, but not paraoxonase-1, on long fatty acyl chain phospholipid hydroperoxides","volume":"282","author":"Kriska","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1194\/jlr.M400213-JLR200","article-title":"Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH","volume":"45","author":"Teiber","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Khattib, A., Musa, S., Halabi, M., Hayek, T., and Khatib, S. (2022). Lyso-DGTS Lipid Derivatives Enhance PON1 Activities and Prevent Oxidation of LDL: A Structure-Activity Relationship Study. Antioxidants, 11.","DOI":"10.3390\/antiox11102058"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbrc.2012.11.128","article-title":"Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability","volume":"430","author":"Mishra","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbamem.2004.04.011","article-title":"Membrane proteins, lipids and detergents: Not just a soap opera","volume":"1666","author":"Seddon","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.freeradbiomed.2004.08.012","article-title":"The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity","volume":"37","author":"James","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.bbapap.2007.05.001","article-title":"Stability of highly purified human paraoxonase (PON1): Association with human phosphate binding protein (HPBP) is essential for preserving its active conformation(s)","volume":"1774","author":"Rochu","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.freeradbiomed.2008.11.019","article-title":"Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects","volume":"46","author":"Tavori","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1073\/pnas.2536901100","article-title":"Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization","volume":"101","author":"Aharoni","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0021-9150(97)00162-7","article-title":"Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein","volume":"135","author":"Graham","year":"1997","journal-title":"Atherosclerosis"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.18.10.1617","article-title":"Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R","volume":"18","author":"Aviram","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(04)15642-0","article-title":"Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: Meta-analysis of 43 studies","volume":"363","author":"Wheeler","year":"2004","journal-title":"Lancet"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.67.5.955","article-title":"A parlous state of storm and stress. The life and times of James B. Herrick","volume":"67","author":"Ross","year":"1983","journal-title":"Circulation"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1096\/fj.201800346R","article-title":"Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans","volume":"32","author":"Borowczyk","year":"2018","journal-title":"FASEB J."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/4\/430\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:08:20Z","timestamp":1760029700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/4\/430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":177,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["antiox14040430"],"URL":"https:\/\/doi.org\/10.3390\/antiox14040430","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]}}}